IHE and Camurus study indicates substantial societal cost reductions associated with opioid dependence treatment in the UK
· Each person with opioid dependence recruited into or retained in treatment for one year was associated with an estimated GBP 140,876 lower societal costs compared with a person not in treatment
· Most cost reductions occurred outside healthcare, primarily distributed among families and communities, economic productivity, and the criminal justice system
· Findings support a cross-sector approach to policy and funding decisions for opioid dependence treatment
Lund, Sweden — 9 November 2026 — Camurus (NASDAQ STO: CAMX) and The Swedish Institute for Health Economics, IHE, today